SWEDENCARE AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55 SEK | +0.64% |
|
0.00% | -9.78% |
| Apr. 25 | Swedencare AB Approves Dividend for the Year 2023, Payable on May 3, 2024 | CI |
| Apr. 25 | Transcript : Swedencare AB, Q1 2024 Earnings Call, Apr 25, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,463 | 6,273 | 18,183 | 4,862 | 9,676 | 8,730 | - | - |
| Enterprise Value (EV) 1 | 1,419 | 6,142 | 18,664 | 6,519 | 11,098 | 9,734 | 9,227 | 8,646 |
| P/E ratio | 48.7 x | 116 x | 314 x | 50.4 x | 165 x | 38.8 x | 24.5 x | 18.2 x |
| Yield | - | 0.25% | 0.13% | 0.72% | 0.38% | 0.91% | 1.45% | 2% |
| Capitalization / Revenue | 11.5 x | 26.1 x | 23.6 x | 2.66 x | 4.16 x | 3.26 x | 2.9 x | 2.57 x |
| EV / Revenue | 11.2 x | 25.6 x | 24.2 x | 3.56 x | 4.77 x | 3.64 x | 3.07 x | 2.55 x |
| EV / EBITDA | 35.9 x | 87.4 x | 144 x | 17.1 x | 22.2 x | 15 x | 11.8 x | 8.67 x |
| EV / FCF | 50.7 x | -10.4 x | -10.7 x | -1.48 x | 41.5 x | 18.1 x | 14.3 x | 11.2 x |
| FCF Yield | 1.97% | -9.59% | -9.34% | -67.6% | 2.41% | 5.54% | 7.02% | 8.94% |
| Price to Book | 11.1 x | 7.28 x | 7.51 x | 0.65 x | 1.34 x | 1.18 x | 1.14 x | 1.09 x |
| Nbr of stocks (in thousands) | 79,010 | 96,510 | 118,150 | 158,112 | 158,732 | 158,732 | - | - |
| Reference price 2 | 18.52 | 65.00 | 153.9 | 30.75 | 60.96 | 55.00 | 55.00 | 55.00 |
| Announcement Date | 2/13/20 | 2/18/21 | 4/6/22 | 2/16/23 | 2/15/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 126.8 | 239.9 | 770.4 | 1,829 | 2,325 | 2,676 | 3,009 | 3,395 |
| EBITDA 1 | 39.53 | 70.3 | 129.7 | 380.7 | 499.3 | 648 | 784.7 | 997.1 |
| EBIT 1 | 36.91 | 60.37 | 64.56 | 120 | 184.2 | 429 | 550.5 | 675.4 |
| Operating Margin | 29.12% | 25.16% | 8.38% | 6.56% | 7.92% | 16.03% | 18.3% | 19.89% |
| Earnings before Tax (EBT) 1 | 36.69 | 58.67 | 56.9 | 80.09 | 81.1 | 288.4 | 456.3 | 613.5 |
| Net income 1 | 29.91 | 48.53 | 54.62 | 94.45 | 58.6 | 224.9 | 355.9 | 478.5 |
| Net margin | 23.6% | 20.23% | 7.09% | 5.16% | 2.52% | 8.4% | 11.83% | 14.1% |
| EPS 2 | 0.3800 | 0.5600 | 0.4900 | 0.6100 | 0.3700 | 1.417 | 2.242 | 3.015 |
| Free Cash Flow 1 | 28.02 | -589.1 | -1,743 | -4,406 | 267.6 | 539.1 | 647.3 | 772.9 |
| FCF margin | 22.1% | -245.5% | -226.22% | -240.84% | 11.51% | 20.14% | 21.51% | 22.77% |
| FCF Conversion (EBITDA) | 70.87% | - | - | - | 53.6% | 83.19% | 82.49% | 77.52% |
| FCF Conversion (Net income) | 93.65% | - | - | - | 456.66% | 239.66% | 181.86% | 161.52% |
| Dividend per Share 2 | - | 0.1600 | 0.2000 | 0.2200 | 0.2300 | 0.5000 | 0.8000 | 1.100 |
| Announcement Date | 2/13/20 | 2/18/21 | 4/6/22 | 2/16/23 | 2/15/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 255.2 | 380.2 | 470.9 | 483.5 | 497.4 | 523.6 | 572.1 | 602 | 627.2 | 598.9 | 664 | 691 | 707 |
| EBITDA 1 | 3.662 | 94.7 | 118.6 | 83.81 | 112.3 | 107.4 | 119.5 | 137 | 135.5 | 138.8 | 166.9 | 185.8 | 195.8 |
| EBIT 1 | -57.77 | 74.98 | 107.3 | 21.64 | 35.28 | 30.3 | 30.9 | 56.7 | 55.3 | 62 | 87.89 | 106.8 | 116.8 |
| Operating Margin | -22.64% | 19.72% | 22.79% | 4.48% | 7.09% | 5.79% | 5.4% | 9.42% | 8.82% | 10.35% | 13.24% | 15.46% | 16.52% |
| Earnings before Tax (EBT) 1 | -59.38 | 2.675 | 32.93 | 11.8 | 17.69 | 10.2 | 9.8 | 32.8 | 28.3 | 35.1 | 66.24 | 85.87 | 96.82 |
| Net income 1 | -34.34 | 11.53 | 77.63 | 24.29 | 15.78 | 17.2 | 16.3 | 38.1 | -13 | 30.1 | 51.67 | 66.98 | 75.52 |
| Net margin | -13.46% | 3.03% | 16.49% | 5.02% | 3.17% | 3.28% | 2.85% | 6.33% | -2.07% | 5.03% | 7.78% | 9.69% | 10.68% |
| EPS 2 | -0.3200 | 0.0800 | 0.4900 | 0.1500 | 0.1000 | 0.1100 | 0.1000 | 0.2400 | -0.0800 | 0.1900 | 0.3255 | 0.4220 | 0.4758 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 4/6/22 | 5/12/22 | 7/28/22 | 11/9/22 | 2/16/23 | 4/28/23 | 7/27/23 | 10/25/23 | 2/15/24 | 4/25/24 | - | - | - |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 481 | 1,657 | 1,421 | 1,004 | 496 | - |
| Net Cash position 1 | 43.8 | 131 | - | - | - | - | - | 83.8 |
| Leverage (Debt/EBITDA) | - | - | 3.707 x | 4.352 x | 2.847 x | 1.55 x | 0.6326 x | - |
| Free Cash Flow 1 | 28 | -589 | -1,743 | -4,406 | 268 | 539 | 647 | 773 |
| ROE (net income / shareholders' equity) | 26.1% | 9.12% | 3.27% | 1.91% | 0.91% | 3.08% | 4.72% | 6.1% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | 1.660 | 8.930 | 20.50 | 47.00 | 45.40 | 46.60 | 48.30 | 50.50 |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 5.11 | 620 | 27.8 | 4,666 | 176 | 79.5 | 75.7 | 81.5 |
| Capex / Sales | 4.03% | 258.25% | 3.61% | 255.06% | 7.59% | 2.97% | 2.52% | 2.4% |
| Announcement Date | 2/13/20 | 2/18/21 | 4/6/22 | 2/16/23 | 2/15/24 | - | - | - |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
55
SEK
Average target price
68
SEK
Spread / Average Target
+23.64%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.78% | 796M | |
| -19.73% | 72.39B | |
| -11.01% | 6.54B | |
| +15.88% | 3.43B | |
| -2.92% | 3.12B | |
| -0.68% | 1.4B | |
| -17.27% | 1.34B | |
| -2.73% | 1.26B | |
| -14.67% | 1.12B | |
| -5.37% | 990M |
- Stock Market
- Equities
- SECARE Stock
- Financials Swedencare AB
